Pilot Testing a Computer Delivered Tobacco Cessation Intervention in Outpatient Clinical Settings: A Feasibility Study
1 other identifier
interventional
18
1 country
1
Brief Summary
The investigators have developed a hybrid computer- and person-delivered intervention, called "C-Raven" for smoking cessation that is tailored to people with tobacco use in Baltimore City. The computer delivered component consists of two \~20 minute sessions on an iPad guided by Edna Poe, an interactive avatar. These sessions are followed by elective in vivo initiation of nicotine replacement therapy (NRT). Community health workers (CHWs) trained in smoking cessation and motivational interviewing provide 6 weeks of supportive follow up counseling. The investigators propose a pilot of the intervention package in the Tobacco Treatment and Lung Cancer Screening Clinic (TTLCSC) at Johns Hopkins Hospital, and the Johns Hopkins Broadway Center for Addiction, assessing feasibility and acceptability of using this tool in these clinical settings. In addition, the investigators will compare whether the use of a virtual counselor is associated with greater satisfaction and engagement with the program. To this end, the investigators propose a two-arm randomized controlled trial, randomizing up to 90 individuals with tobacco use to the current CRAVEN program which includes a virtual counselor, to CRAVEN without a virtual counselor. Primary outcomes include intervention feasibility and acceptability. The investigators will secondarily examine uptake and maintenance of pharmacotherapy for tobacco cessation, readiness to quit smoking, and tobacco cessation (7 day abstinence) at 6 months, patient satisfaction by intervention arm and CHW engagement by intervention arm.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 23, 2021
CompletedFirst Posted
Study publicly available on registry
December 6, 2021
CompletedStudy Start
First participant enrolled
December 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2022
CompletedDecember 1, 2025
November 1, 2025
9 months
November 23, 2021
November 24, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Percent of persons agreeing to participate among those referred
Feasibility will be assessed with percent of persons agreeing to participate among those referred.
3 months
Percent of contacts made with community health worker
Implementation will be assessed with percent of contacts made with community health worker.
3 months
Secondary Outcomes (3)
Readiness to quit smoking as assessed by a visual analog scale
Immediately post intervention
Uptake of pharmacotherapy as assessed by a yes/no response
3 months
Smoking cessation as assessed by 7-day no tobacco use self report
3 months
Study Arms (2)
C-Raven + Avatar
EXPERIMENTALComputer delivered intervention with Avatar as virtual counselor plus linkage to community health worker
C-Raven
ACTIVE COMPARATORComputer-delivered intervention without virtual counselor, with linkage to community health worker
Interventions
Computer delivered intervention with the investigators' avatar; with linkage to community health worker.
Computer delivered intervention without the investigators' avatar; with linkage to community health worker.
Eligibility Criteria
You may qualify if:
- Adults ≥18 years of age receiving care in one of the two specified clinics
- Current daily smoker and has smoked \>100 cigarettes in their lifetime
- English speaking
- Cognitively able to understand proposed research design
You may not qualify if:
- Actively psychotic or other severe mental health symptoms
- Any contraindication to NRT use
- Hearing impaired (unable to listen to audio component of intervention)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins Tobacco Treatment Clinic at Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Geetanjali Chander
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Care providers, investigators and outcome assessors will be blind to avatar versus no avatar conditions
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2021
First Posted
December 6, 2021
Study Start
December 23, 2021
Primary Completion
September 15, 2022
Study Completion
September 15, 2022
Last Updated
December 1, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share